154 related articles for article (PubMed ID: 36345190)
1. Evaluation of prognostic factors and oncological outcomes in patients with limb-localized myxoid liposarcoma.
Büyükceran İ; Erdoğan F; Karadeniz S; Coşkun HS; Dabak N
Jt Dis Relat Surg; 2022; 33(3):616-623. PubMed ID: 36345190
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors of patients with extremity myxoid liposarcomas after surgery.
Wu J; Qian S; Jin L
J Orthop Surg Res; 2019 Mar; 14(1):90. PubMed ID: 30922351
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors for the recurrence of myxoid liposarcoma: 20 cases with up to 8 years follow-up.
Lemeur M; Mattei JC; Souteyrand P; Chagnaud C; Curvale G; Rochwerger A
Orthop Traumatol Surg Res; 2015 Feb; 101(1):103-7. PubMed ID: 25583234
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic prognostic factors of pure myxoid liposarcoma of the extremities and trunk wall.
Nishida Y; Tsukushi S; Nakashima H; Ishiguro N
Clin Orthop Relat Res; 2010 Nov; 468(11):3041-6. PubMed ID: 20499293
[TBL] [Abstract][Full Text] [Related]
5. Surgical Outcomes and Prognostic Factors of Myxoid Liposarcoma in Extremities: A Retrospective Study.
Zheng K; Yu XC; Xu M; Yang Y
Orthop Surg; 2019 Dec; 11(6):1020-1028. PubMed ID: 31721459
[TBL] [Abstract][Full Text] [Related]
6. Radiosensitivity translates into excellent local control in extremity myxoid liposarcoma: a comparison with other soft tissue sarcomas.
Chung PW; Deheshi BM; Ferguson PC; Wunder JS; Griffin AM; Catton CN; Bell RS; White LM; Kandel RA; O'Sullivan B
Cancer; 2009 Jul; 115(14):3254-61. PubMed ID: 19472403
[TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant radiotherapy for myxoid liposarcomas: Oncologic outcomes and histopathologic correlations.
Salduz A; Alpan B; Valiyev N; Özmen E; İribaş A; Ağaoğlu F; Bayram A; Bilgiç B; Özger H
Acta Orthop Traumatol Turc; 2017 Oct; 51(5):355-361. PubMed ID: 28869066
[TBL] [Abstract][Full Text] [Related]
8. Myxoid liposarcoma: local relapse and metastatic pattern in 43 patients.
Dürr HR; Rauh J; Baur-Melnyk A; Knösel T; Lindner L; Roeder F; Jansson V; Klein A
BMC Cancer; 2018 Mar; 18(1):304. PubMed ID: 29558901
[TBL] [Abstract][Full Text] [Related]
9. Is perioperative chemotherapy effective in patients with localized myxoid liposarcoma?
Masunaga T; Tsukamoto S; Nitta Y; Honoki K; Fujii H; Akahane M; Takeda M; Tanaka Y; Mavrogenis AF; Errani C; Kawai A
Jpn J Clin Oncol; 2024 Mar; 54(3):297-304. PubMed ID: 38134204
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of neoadjuvant hypofractionated radiotherapy in patients with locally advanced myxoid liposarcoma.
Koseła-Paterczyk H; Szumera-Ciećkiewicz A; Szacht M; Haas R; Morysiński T; Dziewirski W; Prochorec-Sobieszek M; Rutkowski P
Eur J Surg Oncol; 2016 Jun; 42(6):891-8. PubMed ID: 27026512
[TBL] [Abstract][Full Text] [Related]
11. Extra-abdominal desmoid fibromatosis: An evaluation of clinical factors affecting local recurrence rates.
Coşkun HS; Erdoğan F; Çinka H; Dabak N
Acta Orthop Traumatol Turc; 2021 Dec; 55(6):547-551. PubMed ID: 34967745
[TBL] [Abstract][Full Text] [Related]
12. Complete pathological response to neoadjuvant treatment is associated with better survival outcomes in patients with soft tissue sarcoma: Results of a retrospective multicenter study.
Bonvalot S; Wunder J; Gronchi A; Broto JM; Turcotte R; Rastrelli M; Papai Z; Radaelli S; Lindner LH; Shumelinsky F; Cubillo A; Rutkowski P; Demaire C; Strens D; Nalbantov G
Eur J Surg Oncol; 2021 Aug; 47(8):2166-2172. PubMed ID: 33676792
[TBL] [Abstract][Full Text] [Related]
13. Intermuscular extremity myxoid liposarcoma can be managed by marginal resection following neoadjuvant radiotherapy.
Perera JR; AlFaraidy M; Ibe I; Aoude A; Acem I; van de Sande MAJ; Dessureault M; Turcotte RE; Mottard S; Basile G; Isler M; Saint-Yves H; Eastley N; Stevenson J; Houdek MT; Chung PWM; Griffin AM; Ferguson P; Wunder JS; Tsoi KM
Eur J Surg Oncol; 2023 Feb; 49(2):362-367. PubMed ID: 36243649
[TBL] [Abstract][Full Text] [Related]
14. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic prognostic factors in myxoid liposarcoma: a retrospective study of 49 patients with long-term follow-up.
ten Heuvel SE; Hoekstra HJ; van Ginkel RJ; Bastiaannet E; Suurmeijer AJ
Ann Surg Oncol; 2007 Jan; 14(1):222-9. PubMed ID: 17058128
[TBL] [Abstract][Full Text] [Related]
16. Myxoid\round cell liposarcoma (MRCLS) revisited: an analysis of 418 primarily managed cases.
Moreau LC; Turcotte R; Ferguson P; Wunder J; Clarkson P; Masri B; Isler M; Dion N; Werier J; Ghert M; Deheshi B;
Ann Surg Oncol; 2012 Apr; 19(4):1081-8. PubMed ID: 22052112
[TBL] [Abstract][Full Text] [Related]
17. Analysis of prognostic factors and histopathological response to neoadjuvant chemotherapy in osteosarcoma.
Erdoğan F; Çinka H; Akman BÇ; Coşkun HS; Dabak N
Jt Dis Relat Surg; 2023; 34(1):196-206. PubMed ID: 36700283
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant radiotherapy for extremity and trunk wall atypical lipomatous tumor/well-differentiated LPS (ALT/WD-LPS): a French Sarcoma Group (GSF-GETO) study.
Cassier PA; Kantor G; Bonvalot S; Lavergne E; Stoeckle E; Le Péchoux C; Meeus P; Sunyach MP; Vaz G; Coindre JM; Linassier C; Labib A; Delcambre C; Bay JO; Leyvraz S; Dubergé T; Lagrange JL; Duret A; Blay JY
Ann Oncol; 2014 Sep; 25(9):1854-1860. PubMed ID: 24914041
[TBL] [Abstract][Full Text] [Related]
19. Myxoid/round cell and pleomorphic liposarcomas: prognostic factors and survival in a series of patients treated at a single institution.
Fiore M; Grosso F; Lo Vullo S; Pennacchioli E; Stacchiotti S; Ferrari A; Collini P; Lozza L; Mariani L; Casali PG; Gronchi A
Cancer; 2007 Jun; 109(12):2522-31. PubMed ID: 17510918
[TBL] [Abstract][Full Text] [Related]
20. Influence of site on the therapeutic ratio of adjuvant radiotherapy in soft-tissue sarcoma of the extremity.
Alektiar KM; Brennan MF; Singer S
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):202-8. PubMed ID: 16111590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
